CD8A and neoplasm: showed that short-course hypofractionation could achieve better local and ectopic anti-tumor effects compared with conventional fractionation, such as increasing tumor-specific CD8+ T cells in draining lymph nodes, and concluded that ICI combined with hypofractionated radiotherapy was more effective than conventional fractionation to break immune tolerance and achieve stronger anti-tumor immune effects (47).